Nasdaq

Apollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021

AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...
KELOLAND News

Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity

AUSTIN, TX / ACCESSWIRE / December 13, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...
Nasdaq

Apollo Endosurgery Receives FDA Breakthrough Device Designation for the Orbera(R) Intragastric Balloon for Treatment of Patients with NASH

AUSTIN, TX / ACCESSWIRE / March 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...
Becker's ASC

1st patient enrolled in Apollo Endosurgery study to treat non-alcoholic steatohepatitis: 4 points

Apollo Endosurgery enrolled the first patient in a multi-center randomized controlled trial endoscopic sleeve gastroplasty using Apollo’s OverStitch Endoscopic Suturing System in patients with ...
Business Wire

Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the ...